1
van Leeuwen, Leanne, Doornekamp, Laura, Goeijenbier, Simone, Jong, Wesley, de Jager, Herbert, van Gorp, Eric, Goeijenbier, Marco
Veröffentlicht in: van Leeuwen , L , Doornekamp , L , Goeijenbier , S , Jong , W , de Jager , H , van Gorp , E & Goeijenbier , M 2021 , ' Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital ' , Vaccines , vol. 9 , no. 2 , 69 , pp. 1-9 . https://doi.org/10.3390/vaccines9020069;
2021
Veröffentlicht in: van Leeuwen , L , Doornekamp , L , Goeijenbier , S , Jong , W , de Jager , H , van Gorp , E & Goeijenbier , M 2021 , ' Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital ' , Vaccines , vol. 9 , no. 2 , 69 , pp. 1-9 . https://doi.org/10.3390/vaccines9020069;
2021
2
Tan, Ngoc H, Geers, Daryl, Sablerolles, Roos S G, Rietdijk, Wim J R, Goorhuis, Abraham, Postma, Douwe F, Visser, Leo G, Bogers, Susanne, van Dijk, Laura L A, Gommers, Lennert, van Leeuwen, Leanne P M, Boerma, Annemarie, Nijhof, Sander H, van Dort, Karel A, Koopmans, Marion P G, Dalm, Virgil A S H, Lafeber, Melvin, Kootstra, Neeltje A, Huckriede, Anke L W, van Baarle, Debbie, Zaeck, Luca M, GeurtsvanKessel, Corine H, de Vries, Rory D, van der Kuy, P Hugo M
Veröffentlicht in: SWITCH ON Research Group , Tan , N H , Geers , D , Sablerolles , R S G , Rietdijk , W J R , Goorhuis , A , Postma , D F , Visser , L G , Bogers , S , van Dijk , L L A , Gommers , L , van Leeuwen , L P M , Boerma , A , Nijhof , S H , van Dort , K A , Koopmans , M P G , Dalm , V A S H , Lafeber , M , Kootstra , N A , Huckriede , A L W , van Baarle , D , Zaeck , L M , GeurtsvanKessel , C H , de Vries , R D & van der Kuy , P H M 2023 , ' Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON) : results from the direct boost group of an open-label, multicentre, randomised controlled trial ' , Lancet Infectious Diseases , vol. 23 , no. 8 , pp. 901-913 . https://doi.org/10.1016/S1473-3099(23)00140-8;
2023
Veröffentlicht in: SWITCH ON Research Group , Tan , N H , Geers , D , Sablerolles , R S G , Rietdijk , W J R , Goorhuis , A , Postma , D F , Visser , L G , Bogers , S , van Dijk , L L A , Gommers , L , van Leeuwen , L P M , Boerma , A , Nijhof , S H , van Dort , K A , Koopmans , M P G , Dalm , V A S H , Lafeber , M , Kootstra , N A , Huckriede , A L W , van Baarle , D , Zaeck , L M , GeurtsvanKessel , C H , de Vries , R D & van der Kuy , P H M 2023 , ' Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON) : results from the direct boost group of an open-label, multicentre, randomised controlled trial ' , Lancet Infectious Diseases , vol. 23 , no. 8 , pp. 901-913 . https://doi.org/10.1016/S1473-3099(23)00140-8;
2023